NSW Health Drug and Therapeutics Advisory Community of Practice for COVID-19
NSW TAG is coordinating the Drug and Therapeutics Advisory Community of Practice (DaTA CoP) which aims to provide an opportunity for sharing ideas, strategies, solutions, concerns and escalation pathway with respect to COVID-19 Pandemic preparedness.
- Co-chairs: Prof Sarah Hilmer and Ms Jenny Crane
- Meetings now once monthly (or more frequent as required)
If you would like to join the Community or if you wish to share any information or raise any concerns please email us at firstname.lastname@example.org
See also other communities of practice in NSW established across key clinical specialties to support the response to COVID-19.
2021 Temporary register of life-saving medicines for COVID-19-related issues
last updated 30th August 2021
This temporary COVID-19 LSDR was created in May 2021 to enable ready access to medicines for COVID-19-related issues following discussions at the NSW COVID-19 Drug and Therapeutics Advisory Community of Practice meetings.
Currently lists fondaparinux for VITT treatment.
Other drugs may be listed in the future.
Resources for Medicines Use in the Treatment of COVID-19
Activities & news
|TAG Mail||DaTA CoP SharePoint||Clinical Trials Summary Table|
|Our weekly Tag Mail newsletter now has a dedicated COVID-19 section keeping you up-to-date with the latest national and international news and articles relevant to COVID-19. Available||
The SharePoint site includes list of COVID-19-related enquiries to NSW Medicines Information Pharmacists. Members only site
|A summary table outlining currently registered Clinical Trials relating to treatment/prophylaxis for COVID-19 within NSW public hospitals is available (last updated 13 September 2021)|
Page last updated: 13 September 2021